Morpholino

MO1-mir7a

ID

ZDB-MRPHLNO-150313-1

Name

MO1-mir7a

Previous Names

None

Targets

mir7a-1 (1)
mir7a-2 (1)
mir7a-3 (1)
mir7a-4 (1)

Sequence

5' - ACAACAAAATCACTAGTCTTCCA - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

View all 4 target locations

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-mir7a

Expressed Gene	Anatomy	Figures
lmx1bb	diencephalon	Fig. S5 from Adusumilli et al., 2020
nr4a2a	diencephalon	Fig. S5 from Adusumilli et al., 2020
th	brain diencephalon	Fig. S9, Figure 6 from Adusumilli et al., 2020

Phenotype

Phenotype resulting from MO1-mir7a

No data available

Phenotype of all Fish created by or utilizing MO1-mir7a

Phenotype	Fish	Conditions	Figures
retinal outer nuclear layer cell population proliferation decreased process quality, abnormal	slc45a2^b4/b4 + MO1-mir7a	light damage: retina, constant light, high light intensity	Fig. 10 from Rajaram et al., 2014
retina regeneration process quality, abnormal	slc45a2^b4/b4 + MO1-mir7a	light damage: retina, constant light, high light intensity	Fig. 10 from Rajaram et al., 2014
retinal inner nuclear layer cell population proliferation decreased process quality, abnormal	slc45a2^b4/b4 + MO1-mir7a	light damage: retina, constant light, high light intensity	Fig. 10 from Rajaram et al., 2014
diencephalon th expression amount, ameliorated	ia4Tg + MO1-mir7a	chemical treatment by environment: XAV939	Fig. S9 from Adusumilli et al., 2020
brain GFP expression increased amount, abnormal	ia4Tg + MO1-mir7a	standard conditions	Figure 6 from Adusumilli et al., 2020
brain th expression increased amount, abnormal	ia4Tg + MO1-mir7a	standard conditions	Figure 6 from Adusumilli et al., 2020
diencephalon GFP expression increased amount, abnormal	ia4Tg + MO1-mir7a	standard conditions	Figure 2 , Figure 3 from Adusumilli et al., 2020
diencephalon Wnt signaling pathway increased occurrence, abnormal	ia4Tg + MO1-mir7a	standard conditions	Figure 3 from Adusumilli et al., 2020
brain Wnt signaling pathway increased occurrence, abnormal	ia4Tg + MO1-mir7a	standard conditions	Figure 2 from Adusumilli et al., 2020
diencephalon th expression increased amount, abnormal	ia4Tg + MO1-mir7a	chemical treatment by environment: Wnt signalling activator	Fig. S9 from Adusumilli et al., 2020
diencephalon th expression increased amount, abnormal	ia4Tg + MO1-mir7a	control	Fig. S9 from Adusumilli et al., 2020
diencephalon nr4a2a expression increased amount, abnormal	ia5Tg + MO1-mir7a	standard conditions	Fig. S5 from Adusumilli et al., 2020
diencephalon lmx1bb expression increased amount, abnormal	ia5Tg + MO1-mir7a	standard conditions	Fig. S5 from Adusumilli et al., 2020
diencephalon mCherry expression increased amount, abnormal	ia5Tg + MO1-mir7a	standard conditions	Fig. S5 from Adusumilli et al., 2020
telencephalon EGFP expression decreased amount, abnormal	vu12Tg + MO1-mir7a	standard conditions	Figure 8 from Adusumilli et al., 2020
diencephalon EGFP expression decreased amount, abnormal	vu12Tg + MO1-mir7a	standard conditions	Figure 8 from Adusumilli et al., 2020
hindbrain EGFP expression decreased amount, abnormal	vu12Tg + MO1-mir7a	standard conditions	Figure 8 from Adusumilli et al., 2020
diencephalon Wnt signaling pathway increased occurrence, abnormal	ia5Tg; nu15Tg; y1Tg + MO1-mir7a	standard conditions	Fig. S8 from Adusumilli et al., 2020
diencephalon smoothened signaling pathway decreased occurrence, abnormal	ia5Tg; nu15Tg; y1Tg + MO1-mir7a	standard conditions	Fig. S8 from Adusumilli et al., 2020
telencephalon diencephalon boundary smoothened signaling pathway decreased occurrence, abnormal	nu15Tg; y1Tg + MO1-mir7a	standard conditions	Figure 8 from Adusumilli et al., 2020
brain smoothened signaling pathway decreased occurrence, abnormal	nu15Tg; y1Tg + MO1-mir7a	standard conditions	Figure 8 from Adusumilli et al., 2020
forebrain midbrain boundary smoothened signaling pathway decreased occurrence, abnormal	nu15Tg; y1Tg + MO1-mir7a	standard conditions	Figure 8 from Adusumilli et al., 2020
hypothalamus smoothened signaling pathway decreased occurrence, abnormal	nu15Tg; y1Tg + MO1-mir7a	standard conditions	Figure 8 from Adusumilli et al., 2020

Citations